1.The existing problems and suggestion on the development of hospital post-doctoral scientific research station
Zhonghe SUN ; Xiaolan CHEN ; Yaze ZHAO
Chinese Journal of Medical Education Research 2017;16(8):860-864
This study explored the current problems regarding post-doctoral scientific research station including rigid system,low fund coverage,uncooperative team,lack of innovation and independent research capacities etc.To address above-mentioned problems,the assessment process of admission to the research station should be defined,multidisciplinary academic exchanges enhanced,evaluation and incentive mechanism developed,reasonable restraint mechanism for supervisors established,and self-management of the students carried out and practical funding projects supplemented,thus cultivating a team of high-level medical talents to lead the disciplinary development.
2.Effect of digital acupoint pressure combined with physical therapy on stroke patients with hemiplegia at early stage
XIianxian TIAN ; Zhonghe ZHAO ; Zhenghao LIN
Chinese Journal of Rehabilitation Theory and Practice 2005;11(8):609-610
ObjectiveTo observe the effect of digital acupoint pressure combined with physical therapy on stroke patients with hemiplegia at early stage.Methods126 stroke patients with hemiplegia were randomly divided into the observation group (64 cases) and control group (62 cases). Patients of the observation group were treated with digital acupoint pressure and physical therapy, and cases of the control group were treated only with physical therapy. The therapeutic effects of tow groups were evaluated after four-week treatment.ResultsIn all cases, no bad effects or new bleeding and cerebral infarction occurred during treatment. Scores of Brunnstrom scale, Fugl-Meyer assessed and neural function defects scale of the observation group were significantly superior to the control group (P<0.05).ConclusionThe digital acupoint pressure combined with physical therapy is safe to hemiplegic patients at early stage and the effect is better than physical therapy alone.
3.Curative effect of cervical traction combined with low-cycle or intermediate frequency electrical current in cervical vertebrae
Dongqing CHEN ; Zhonghe ZHAO ; Jiaming WU ; Fenhua MA
Chinese Journal of Primary Medicine and Pharmacy 2009;16(8):1407-1408
Objective To observe the curative effect of cervical traction combined with low-cycle or intermediate frequency electrical current in cervical vertebrae.Methods 171 patients with cervical vertebrae were randomly divided into the therapy group and control group,86 cases in therapy group were performed the curative measure of cervical traction and low-cycle,85 cases in control group underwent the curative measure of cervical traction and intermediate frequency electrical current.Both of the two groups carried out continuous therapy for 10 days.Results There was significant difference before and after treatment within each group in CASCS score(P < 0.01)and there was also significant difference after treatment between the two groups(P < 0.05),the effective rate of therapy groupwas significant higher than that of control group(P < 0.05).Conclusion The methods of cervical traction and low cycle or intermediate frequency electrical current has better curative effect in cervical vertebrae and cervical traction and low-cycle do much benefit in cervical vertebrae treatment.
4.Curative effect of interference current and direct current pharmaceutical iontophoresis in patients with retrograde gonarthritis
Dongqing CHEN ; Zhonghe ZHAO ; Jiaming WU ; Fenhua MA
Chinese Journal of Primary Medicine and Pharmacy 2009;16(7):1205-1206
Objective To observe and analyse the efficacy of retrograde gonarthritis with interference current and drug-iontophoresis direct current. Methods 185 patients with retrograde gonarthritis were randomly divided into treatment group 92 cases and control group 93 cases. The patients in treatment group underwent interference current and drug-iontophoresis direct current and patients in control group performed modulated medium frequency drug-ionto-phoresis direct current for two treatment courses. Results The comprehensive score of various kind of symptom such as pain、swelling、flexion、walking ability, up-down stair ability in treatment group significantly improved than that of control group (P < 0.01). Conclusion The interference current and drug-iontophoresis direct current is one of effec-tive and safe measurement in treating arthritis with main manifestation of pain and soft tissue disease.
5.The capability of high field MRI in demonstrating post-mortem fetal brains at different gestational age
Zhonghe ZHANG ; Shuwei LIU ; Xiangtao LIN ; Gaojun TENG ; Taifei YU ; Fang FANF ; Bin ZHAO ; Fengchao ZANG ; Hequn GENG
Chinese Journal of Radiology 2009;43(11):1131-1134
Objective To study the capability of high field MRI in demonstrating the post-mortem fetal brains at different gestational age(GA).Methods One hundred and eight post-mortem fetal brains of 14-40 weeks GA were evaluated by 3.0 T MRI. Eleven brains of 14 to 27 weeks GA with good 3.0 T MRI images were chosen and scanned by 7.0 T MRI. The developing sulci, layered structures of fetal cerebral cortex and basal nuclei were evaluated on MRI of different Tesla(3.0 T and 7.0 T)and their results analyzed. Results On T_1 WI of 3.0 T MRI, the layered structures of fetal cerebral cortex were present at 14 weeks GA, the sulci were more accurately identified after 16 weeks GA. The basal nuclei were clearly distinguishable after 20 weeks GA. and these structures were better visualized as the GA increased. On T_2WI of 7.0 T MRI, the sulei, layered structures of fetal cerebral cortex and basal nuclei were shown more clearly at the same GA when compared to 3.0 T, especially the sulci at the early developmental stages. Conclusions T_1 WI of 3.0 T MRI could show the developing structures of post-mortem fetal brain well, but the T_2 WI of 7.0 T MRI were comparatively better.
6.Multicenter postmarketing clinical study on using pegylated recombinant human gran-ulocyte-colony stimulating factor to prevent chemotherapy-induced neutropenia
Yuankai SHI ; Jianping XU ; Changping WU ; Yan ZHANG ; Junquan YANG ; Tao ZHOU ; Zheng LIU ; Weidong MAO ; Yiping ZHANG ; Wei WANG ; Zhonghe YU ; Lin WU ; Jianhua CHEN ; Juan WANG ; Yonghui AN ; Jianhui CAI ; Ming LIU ; Zhendong CHEN ; Qingshan LI ; Chaoying REN ; Zhiyong YANG ; Baolan LI ; Min ZHAO ; Zhefeng LIU ; Bin LIU
Chinese Journal of Clinical Oncology 2017;44(14):679-684
Objective: To investigate the efficacy and safety of using pegylated recombinant human granulocyte-colonystimulating factor (PEG-rhG-CSF) in preventing neutropenia in multiple chemotherapy cycles. Methods: A multicenter, prospective, open-label, singlearmstudy was designed. Patients with malignant tumors, such as lung, ovarian, and colorectal cancers, who received multiple cycles of chemotherapy with the prophylactic use of PEG-rhG-CSF for 2-4 consecutive cycles participated in the study. Results: After the prophylactic use of PEG-rhG-CSF, the incidence of grade IV neutropenia decreased from 4.76% (13/273) in the first cycle to 1.83% (5/273), 1.15% (2/174), and 2.08% (2/96) in subsequent cycles. Meanwhile, the incidence of grade III neutropenia decreased from 11.36% (31/ 273) in the first cycle to 6.23% (17/273), 2.87% (5/174), and 3.13% (3/96) in subsequent cycles. The incidence of febrile neutropenia (FN) during the first cycle was 0.73% (2/273). The duration of FN was 2 days in one case and 5 days in another case. FN was not observed during the second, third, or fourth cycle. After the secondary prophylactic use of PEG-rhG-CSF, the incidence of grade IV neutropenia decreased from 25% (7/28) to 3.57% (1/28), 0% (0/28), and 6.67% (1/15) in subsequent cycles. Meanwhile, the incidence of grade III neutropenia decreased from 71.43% (20/28) to 10.71% (3/28), 14.29% (4/28), and 0% (0/15) in subsequent cycles. The proportion of patients who received antibiotic therapy during the entire chemotherapy period was 10.48% (44/420). Conclusion: The application of PEG-rhG-CSF once per chemotherapy cycle can effectively reduce the occurrence of neutropenia in patients under multiple cycles of chemotherapy treatment with good safety.
7.Analysis of a case of perinatal anaphylactic shock caused by esketamine
Liangfen WANG ; Mengjie HE ; Man LIU ; Yue ZHAO
China Pharmacy 2024;35(18):2299-2303
OBJECTIVE To provide a reference for medical staff to timely identify and treat perinatal anaphylactic shock. METHODS The clinical pharmacists participated in the rescue process of anaphylactic shock caused by esketamine during cesarean section anesthesia in a full-term pregnant patient at the Department of Obstetrics and Gynecology of Sichuan Provincial Maternity and Child Health Care Hospital. By consulting the relevant drug instructions and searching the relevant literature, clinical pharmacists assisted physicians in identifying anaphylactic shock and amniotic fluid embolism, analyzing the correlation between the drugs used and adverse reactions, and providing medication education. RESULTS The patient developed hypoxemia and hypotension after anesthesia, and there was no coagulation dysfunction. After symptomatic treatment with adrenaline, the condition rapidly improved, so it was diagnosed as anaphylactic shock. Based on the patient’s medication use and the characteristics of adverse reactions, combined with the National Adverse Drug Reaction Monitoring Center’s criteria for determining the association between drugs and adverse reactions and Naranjo’s evaluation scale, it was comprehensively determined that the suspected allergenic drug causing anaphylactic shock was esketamine. The clinical pharmacist informed the patient that she must inform the physician of the relevant medications for this severe allergic reaction during her later visits. The patient recovered and was discharged on the 6th day after cesarean section. CONCLUSIONS The clinical manifestations of anaphylactic shock and amniotic fluid embolism are similar, and careful differentiation is needed in clinical practice; if a patient experiences a systemic allergic reaction caused by drugs, the suspected drugs should be stopped promptly and effective symptomatic treatment should be taken immediately to delay or terminate disease progression and ensure the patient’s life safety.